| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |